XBiotech
XBIT
43 hedge funds and large institutions have $16.9M invested in XBiotech in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 15 increasing their positions, 16 reducing their positions, and 4 closing their positions.
30% more capital invested
Capital invested by funds: $13M → $16.9M (+$3.91M)
0.4% less ownership
Funds ownership: 9.33% → 8.93% (-0.4%)
6% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 16
2% less funds holding
Funds holding: 44 → 43 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
36% less call options, than puts
Call options by funds: $207K | Put options by funds: $325K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
+$55.7K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$42.3K |
| 3 |
Nisa Investment Advisors
St. Louis,
Missouri
|
+$40.1K |
| 4 |
State Street
Boston,
Massachusetts
|
+$37.8K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
+$29.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$260K |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$140K |
| 3 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$111K |
| 4 |
Millennium Management
New York
|
-$86K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$77.2K |
XBIT Hedge Fund Activity: Q1 2018 in Review
43 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q1 2018, worth a combined $16.9M — up 30% from $13M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of XBIT and 3 opened new positions — a net loss of 1 holder — while 16 trimmed existing stakes and 15 added.
The largest buyer was Dimensional Fund Advisors, adding an estimated $55.7K. The largest seller was Goldman Sachs, cutting an estimated $260K.
- 43 institutional investors held XBiotech (XBIT) as of Q1 2018, down from 44 in Q4 2017.
- Funds reported $16.9M of XBiotech stock for Q1 2018, up 30% quarter-over-quarter.
- 3 funds opened new XBiotech positions in Q1 2018 and 4 closed out, a net change of -1 holder.
- The largest XBiotech buyer in Q1 2018 was Dimensional Fund Advisors, an estimated $55.7K added.
- The largest XBiotech seller in Q1 2018 was Goldman Sachs, an estimated $260K sold.
Based on aggregated 13F filings for Q1 2018.